EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology uses the power of enzymes to create sustainable products and processes for a variety of industries, announced that it had patented a process to synthesize pseudouridine, a key ingredient in mRNA COVID-19 vaccines.
EnginZyme and its CDMO partner, Ajinomoto Bio-Pharma Services,...
Dyno Therapeutics, Inc., a techbio company pioneering applications of artificial intelligence to engineer AAV capsids that can expand the potential of genetic medicine, announced the launch of its Dyno eCap 1™ capsid product, a leading eye AAV gene delivery vector with best-in-class potential, in a keynote address at the...
Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building flexible, scalable solutions for life sciences organizations to Trinity.
As CTO, Mr. Rangachari will infuse technology...
Ceremorphic, a fabless silicon and system development company, announced the formation of a new life sciences division called “Ceremorphic Life Sciences,” which has been established to transform the entire drug discovery and development process. The new division will have access to Ceremorphic’s own proprietary analog and AI technology platform...
Insmed Incorporated, a global biopharmaceutical company, announced a collaboration with Google Cloud to transform the drug discovery, development, and commercialization landscape of the life sciences industry through the use of generative AI. This alliance will harness the power of Google Cloud's cutting-edge AI technology and Insmed's expertise in serious...
First out-of-the-box, low-code SaaS platform designed together by scientists and technologists to shorten drug discovery funnel, reduce costs of drug therapy R&D
Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announced the launch of Dotmatics Luma™, a revolutionary new scientific data platform that helps scientists and...
LumiraDx Limited, a next-generation point of care diagnostics company, is pleased to announce a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub, set to go live in November.
The official charity of Everton Football Club will run this...
ZoomRx, a pioneering force in technological solutions for the life sciences sector, announced the launch of their latest innovation: the Ferma Engine. This groundbreaking platform serves as both an incubator and innovation hub for pharma and biotech professionals to build their own generative AI solutions.
At its core, the Ferma...
ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced its strategic collaboration with Optellum Ltd (Oxford, UK), a global leader in AI clinical decision support for early lung cancer diagnosis and precision treatment planning. Through this partnership, the Optellum Virtual Nodule Clinic solution will be seamlessly integrated...
AI has become an increasingly valuable tool in the field of biotechnology. Across various sectors like pharmaceuticals, healthcare, animal husbandry, agriculture, and AI and machine learning (ML) technologies are reshaping processes to achieve more precise and efficient outcomes. The integration of AI in biotechnology holds immense potential for driving...
